Markets

Boston Scientific Corp

stock
BSX· NYSE· Health Care

43.84

+1.11 (+2.60%)

Price as of 13 Oct, 19:40 · Rate limit reached. Please try again in a minute.

31 Aug4 Sept11 Sept17 Sept23 Sept29 Sept5 Oct9 Oct3942454851
Open—
Mkt cap65.44bn USD
Dividend—
High—
P/E ratio18.42
PEG ratio0.55
Low—
52-wk high—
52-wk low—
39

Good Money Guide Pro Score

Weak

Weak investment profile

Technical Analysis

Short-Term Outlook

Bullish

3 bull · 0 bear · 2 neutral

Medium-Term Outlook

Bearish

1 bull · 3 bear · 0 neutral

Moving Average (50d)
Bearish
46.48

Price below 50-day MA

Moving Average (200d)
Bearish
60.15

Price below 200-day MA

EMA (12d)
Bullish
43.08

Price above 12-day EMA

EMA (26d)
Bearish
44.01

Price below 26-day EMA

RSI (14)
Neutral
48.5

Neutral momentum zone

MACD
Bullish
-0.94

MACD above signal line

Stochastic Oscillator
Bullish
56.3%

%K above %D

Bollinger Bands
Neutral
43.44

Price near middle band

Standard Deviation
Neutral
0.90

Volatility measure — informational only

Volume Indicators

On Balance Volume (OBV)

20 May22 Jun22 Jul20 Aug21 Sept-540000000-450000000-360000000-180000000

Volume Accumulation Distribution (VAD)

20 May22 Jun22 Jul20 Aug21 Sept-420000000-350000000-280000000-140000000

Market Statistics

Day Change

+1.11

Market Cap

65444217000

Exchange

NYSE

Sector

Health Care

Fundamentals

Rate limit reached. Please try again in a minute.

Analyst Forecast

Rate limit reached. Please try again in a minute.

Fundamental Analysis

Unable to load fundamental data

Learn about Boston Scientific Corp

What is Boston Scientific Corp?

Boston Scientific Corporation is a global medical technology company that develops and manufactures devices for use in various medical specialties, including interventional cardiology, endoscopy, and urology. The company focuses on creating minimally invasive technologies designed to improve patient health outcomes and reduce the need for complex surgeries. Their products are sold to hospitals, clinics, and medical practices worldwide.

Is Boston Scientific Corp a good investment?

Boston Scientific benefits from a strong portfolio of innovative medical products and a growing aging population, which drives long-term demand for their devices. However, the company faces significant challenges, including intense competition, strict regulatory scrutiny, and the potential for costly product recalls. Please note that this information is for educational purposes only and does not constitute professional financial advice.

How do you invest in Boston Scientific Corp?

You can invest in Boston Scientific by purchasing shares of the company (ticker: BSX) through a registered online brokerage account or investment platform. Alternatively, you can gain exposure to the stock by investing in healthcare-focused exchange-traded funds (ETFs) or mutual funds that include Boston Scientific in their holdings.

Educational content generated by AI — not financial advice.

Time & Sales

No trades yet.

News & Sentiment

Rate limit reached. Please try again in a minute.

Share your opinion

Log in or sign up to share your opinion.

Sign up

Community Discussion

No posts yet for BSX — be the first to start the discussion.

Trade

Log in or sign up to place simulated trades.

Sign up

Point & Figure Analysis

OHLC

O: 43.10
H: 43.92
L: 42.67
C: 43.84
V: 13,596,400

Signals

as of 12 Oct 2026
TrendBear
RelativeBear ▼
Strength
Last Climax (SELL)(04 Feb 2026)
Last KDR (BOUNCE)(02 Sept 2026)
Last POS (REVERSAL)(08 Oct 2026)
Last MA Crossover(DEATH) 16 Oct 2025

Targets

Bear to:40.00 ▼
Stop loss at:50.00

© 2026 Good Money Guide Pro. All rights reserved.

All content copyright Good Money Guide Pro. Good Money Guide Pro is a registered trademark and is owned and operated by RJBCO Ltd. Registered in England & Wales, Company Number: 07134687. Registered office at 11 Old Bond Street, Mayfair, London W1S 4PN. VAT registration number: 324242143. Data protection registration number: ZA468875.

The information contained in this website is for informational purposes only and does not constitute financial advice. The material does not contain (and should not be construed as containing) investment advice or an investment recommendation, or, an offer of or solicitation for, a transaction in any financial instrument.